Pendal Group’s STAAR Surgical STAA Stock Holding History

Pendal Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,300	Closed	-$301K	–	565
2021 Q4	$301K	Buy	+3,300	New	+$354K	﹤0.01%	508

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Pendal Group's STAA Position: Q1 2022 in Review

Pendal Group sold out of STAAR Surgical (STAA) in Q1 2022, closing a stake of 3,300 shares — an estimated $301K sold.

Pendal Group first reported a position in STAA in Q4 2021 and held it in 1 quarter. The position peaked at $301K in Q4 2021. 270 funds tracked by Wall St. Rank hold STAA as of Q1 2022.

Pendal Group reported no remaining STAAR Surgical position as of Q1 2022 after selling out during the quarter.
Pendal Group sold 3,300 STAAR Surgical shares in Q1 2022, an estimated $301K.
Pendal Group first reported a position in STAAR Surgical in Q4 2021 and held it in 1 quarter.
Pendal Group's STAAR Surgical position peaked at $301K in Q4 2021.
270 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2022.

Based on Pendal Group's 13F filing for Q1 2022, filed 25 Apr 2022.